1. Orgaran (Org10172): Its pharmacological profile in experimental models;Meuleman;Haemost,1992
2. Anticoagulant mechanisms od Orgaran (Org 10172) and its fraction the high affinity to antithrombin III (Org 10849);Ofosu;Haemost,1992
3. Heparin-induced thrombocytopenia: in-vitro studies with a new low molecular weight heparinoid, Org 10172;Chong;Blood,1989
4. Heparin-induced thrombocytopenia – therapeutic concentrations of danaparoid unlike fondaparinux and direct thrombin inhibitors, inhibit formation of PF4/heparin complexes;Krauel;J Thromb Haemost,2008
5. Pharmacological and clinical strudies with Lomoparan, a low molecular weight glycosaminoglycan;Nurmohamed;Semin Thromb Hemost,1991